K864456 is an FDA 510(k) clearance for the CYCLOSPORIN A (WHOLE BLOOD) CONTROL - LEVELS 1,2,3. Classified as Drug Specific Control Materials (product code LAS), Class I - General Controls.
Submitted by Cala Diagnostics (Los Osos, US). The FDA issued a Cleared decision on May 6, 1987 after a review of 174 days - an extended review cycle.
This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3280 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all Cala Diagnostics devices